Influenza: The rational use of oseltamivir

The Lancet

Volumn 385, Issue 9979, 2015, Pages 1700-1702

  Kelly, Heath ^a,b   Cowling, Benjamin J ^c  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b The Australian National University   (Australia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ANTIVIRUS AGENT;

ANTIBODY TITER; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; FLU LIKE SYNDROME; HOSPITAL ADMISSION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INTENTION TO TREAT ANALYSIS; LOWER RESPIRATORY TRACT INFECTION; META ANALYSIS (TOPIC); NAUSEA; NOTE; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAPID TEST; SENSITIVITY AND SPECIFICITY; VOMITING; INFLUENZA, HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIVIRAL AGENTS; HUMANS; INFLUENZA, HUMAN; OSELTAMIVIR; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84929027809     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60074-5     Document Type: Note

References (15)

1. E Goldstein, C Viboud, V Charu, M Lipsitch Improving the estimation of influenza-related mortality over a seasonal baseline Epidemiology 23 2012 829 838
2. RG Pebody, HK Green, N Andrews et al. Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season Eurosurveillance 19 2014 20823
3. M Baguelin, S Flasche, A Camacho, N Demiris, E Miller, WJ Edmunds Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study PLoS Med 10 2013 e1001527
4. T Jefferson, P Doshi Multisystem failure: the story of anti-influenza drugs BMJ 348 2014 g2263
5. J Dobson, RJ Whitley, S Pocock, AS Monto Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials Lancet 2014 published online Jan 30. http://dx.doi.org/10.1016/S0140-6736(14)62449-1
6. T Jefferson, M Jones, P Doshi, EA Spencer, I Onakpoya, CJ Heneghan Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments BMJ 348 2014 g2545
7. P Doshi, M Jones, T Jefferson Rethinking credible evidence synthesis BMJ 344 2012 d7898
8. AG Dunn, D Arachi, J Hudgins, G Tsafnat, E Coiera, FT Bourgeois Financial conflicts of interest and conclusions about neuraminidase inhibitors for influenza: an analysis of systematic reviews Ann Intern Med 161 2014 513 518
9. GH Lyman, NM Kuderer The strengths and limitations of meta-analyses based on aggregate data BMC Med Res Methodol 5 2005 14
10. T Jefferson, M Jones, P Doshi, C Del Mar Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis BMJ 339 2009 b5106
11. L Brammer, L Blanton, S Epperson et al. Surveillance for influenza during the 2009 influenza A (H1N1) pandemic - United States, April 2009-March 2010 Clin Infect Dis 52 2011 S27 S35
12. DE Sutter, SA Worthy, DM Hensley et al. Performance of five FDA-approved rapid antigen tests in the detection of 2009 H1N1 influenza A virus J Med Virol 84 2012 1699 1702
13. SG Muthuri, S Venkatesan, PR Myles et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data Lancet Respir Med 2 2014 395 404
14. AE Fiore, A Fry, D Shay et al. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 60 2011 1 24
15. WHO WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses 2010 World Health Organization Geneva